Alflutinib
Alflutinib (Firmonertinib) is a small molecule EGFR inhibitor targeting both activating mutations and the T790M resistance mutation. It is used in research applications, including in vitro and in vivo studies, to investigate its antitumor efficacy in models of non-small cell lung cancer (NSCLC) .
Product Specifications
CAS Number
1869057-83-9
Product Name Alternative
CYP3A4, Alflutinib, cancer, ASK 120067, ASK120067, ASK-120067, AST 2818, AST2818, AST-2818, esistant mutation, Furmonertinib, ErbB-1, Epidermal growth factor receptor, EGFR, Firmonertinib, Inhibitor, HER1, inhibit, NSCLC, T790M
Field of Research
Cardiovascular Research, Metabolism Research, Signal Transduction
Purity
99.61% (May vary between batches)
Solubility
DMSO:10.83 mg/mL (19.05 mM)
Smiles
CN1C=C (C=2C1=CC=CC2) C3=NC (NC4=C (OCC (F) (F) F) N=C (N (CCN (C) C) C) C (NC (C=C) =O) =C4) =NC=C3
Molecular Formula
C28H31F3N8O2
Molecular Weight
568.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-41670M-BF405 100 µL
Prostate Specific Antigen Monoclonal Antibody, AbBy Fluor™ 405 Conjugated
Sign In for Pricing
View Details